Atossa Therapeutics, Inc. (ATOS)
$2.44+0.83%Close
BUYRECOVERY · day 7
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $24M
- Beta
- 1.27
- P/E (TTM)
- -0.56
- Short % float
- 9.19%
- Days to cover
- 11.3
- SI change
- +3.4%
- 1W
- +4.27%
- 1M
- +4.27%
- vs SPY 1W
- +3.11%
- vs SPY 1M
- +1.28%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on ATOS?
- LOPJLB’s latest quantitative signal on Atossa Therapeutics, Inc. (ATOS) is BUY in a RECOVERY regime. Signals are updated daily.
- What market regime is ATOS in?
- Atossa Therapeutics, Inc. (ATOS) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does Atossa Therapeutics, Inc. (ATOS) do?
- Atossa Therapeutics, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing innovative medicines. Their primary focus lies in addressing unmet medical needs in women's oncology, especially breast cancer, along with other conditions, within the United States. The company's flagship therapeutic candidate is oral (Z)-endoxifen. This compound, an active metabolite derived from tamo…